TNF Receptor 1 Promotes Early-Life Immunity and Protects against Colitis in Mice

Neutralization of tumor necrosis factor (TNF) represents a widely used therapeutic strategy for autoimmune diseases including inflammatory bowel disease (IBD). However, the fact that many patients with IBD are non-responsive to anti-TNF therapies suggests the need for a better understanding of TNF s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Rep
Autors principals: Liu, Cambrian Y., Tam, Sharon S., Huang, Ying, Dubé, Philip E., Alhosh, Rabea, Girish, Nandini, Punit, Shivesh, Nataneli, Shirin, Li, Fan, Bender, Jeffrey M., Washington, M. Kay, Polk, D. Brent
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7682618/
https://ncbi.nlm.nih.gov/pubmed/33086075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2020.108275
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars